Candani A. Tutuka
Melbourne Austin Branch
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue.
Journal: Journal of immunological methods
Published: May 23, 2021
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.
Journal: Cancers
Published: March 22, 2021
PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.
PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.
Journal: Frontiers in immunology
Published: February 25, 2021
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2020
Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis.
Journal: Clinical & translational immunology
Published: October 24, 2019
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Journal: Science (New York, N.Y.)
Published: June 28, 2019
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.
Journal: Frontiers in immunology
Published: December 15, 2017
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.
Journal: Molecular cancer
Published: December 07, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026